MENU
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.19B
P/E Ratio
N/A
Total Cash
5.76M
Projected Growth
N/A
Total Debt
88.54M
Revenue
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
1.52 USD as % of share price
Fundamentals
AUPH
Capitalization
1.19B
P/E Ratio
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
5.76M
Total Cash/Share
0.04
Total Debt
88.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.52%
Revenue
N/A
ROE
N/A
Book Value
359M
P/B Ratio
3.07
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.21B
Current Ratio
5.60
Current Revenue Per Employee
167676.67
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
84.59
Revenue To Assets
N/A
Shares Held By Institutions
490M
Shares Outstanding - Current
143M
Total Liabilities
157M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-7.341
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com